| Dr George A Zaverdas, MD | |
|
444 Roxbury Rd, Rockford, IL 61107-5059 | |
| (815) 398-3000 | |
| (815) 391-5096 |
| Full Name | Dr George A Zaverdas |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 44 Years |
| Location | 444 Roxbury Rd, Rockford, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295798742 | NPI | - | NPPES |
| P00759207 | Other | IL | RR MEDICARE |
| 036063061 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 036-063061 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Osf Saint Paul Medical Center | Mendota, IL | Hospital |
| Osf Saint Anthony Medical Center | Rockford, IL | Hospital |
| Kishwaukee Community Hospital | Dekalb, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.
Noting more than 20,000 international HIV researchers and activists will gather in Washington, D.C., for the AIDS 2012 conference later this month, the Associated Press writes that there is "a sense of optimism not seen in many years - hope that it finally may be possible to dramatically stem the spread of the AIDS virus."
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.
Keryx Biopharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 clinical program for Zerenex(TM) (ferric citrate), its iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD).
More than a third of people in the UK fear cancer more than other life-threatening conditions - such as Alzheimer's, stroke and heart disease according to a Cancer Research UK survey.
› Verified 1 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.
Noting more than 20,000 international HIV researchers and activists will gather in Washington, D.C., for the AIDS 2012 conference later this month, the Associated Press writes that there is "a sense of optimism not seen in many years - hope that it finally may be possible to dramatically stem the spread of the AIDS virus."
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.
Keryx Biopharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 clinical program for Zerenex(TM) (ferric citrate), its iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD).
More than a third of people in the UK fear cancer more than other life-threatening conditions - such as Alzheimer's, stroke and heart disease according to a Cancer Research UK survey.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George A Zaverdas, MD 444 Roxbury Rd, Rockford, IL 61107-5059 Ph: (815) 398-3000 | Dr George A Zaverdas, MD 444 Roxbury Rd, Rockford, IL 61107-5059 Ph: (815) 398-3000 |
News Archive
Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.
Noting more than 20,000 international HIV researchers and activists will gather in Washington, D.C., for the AIDS 2012 conference later this month, the Associated Press writes that there is "a sense of optimism not seen in many years - hope that it finally may be possible to dramatically stem the spread of the AIDS virus."
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, recently announced that their technology is now being incorporated into groundbreaking research in Spain in partnership with the University of Navarra, and involving over 800 participants.
Keryx Biopharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 clinical program for Zerenex(TM) (ferric citrate), its iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD).
More than a third of people in the UK fear cancer more than other life-threatening conditions - such as Alzheimer's, stroke and heart disease according to a Cancer Research UK survey.
› Verified 1 days ago
Dr. Adekola Abioudun Ashaye, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 W State St, Rockford, IL 61102 Phone: 815-490-1600 Fax: 815-490-1881 | |
Prasad K. Kilaru, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2350 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-2000 | |
David R. Mitchell, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5970 Churchview Dr, Rockford, IL 61107 Phone: 815-971-2000 | |
Dr. Amrutha Mary George, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1253 N Alpine Rd, Rockford, IL 61107 Phone: 779-696-9201 | |
Rajyalaxmi Mullapudi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-226-2000 | |
Geoffrey Tsaras, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1340 Charles St Ste 404, Rockford, IL 61104 Phone: 779-696-1890 Fax: 779-696-2410 | |
Stephanie Birmingham, APN Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-5000 |